Literature DB >> 3532604

Long-term antibody response after measles vaccination in an isolated arctic society in Greenland.

I R Pedersen, C H Mordhorst, T Ewald, H von Magnus.   

Abstract

Scoresbysund is an isolated district on the east coast of Greenland with 500 inhabitants, mainly Polar Eskimos, which had never been exposed to natural measles. In 1968 more than 90% of the population were vaccinated with the Schwarz live further-attenuated measles vaccine and subsequently children born after 1968 likewise received the measles vaccination. Upon the initial measles vaccination no clinical cases of measles have been observed. The immunity status of the isolated population has been followed for 16 years after vaccination by IgM, IgA, and IgG ELISA tests and by HI test on a series of serum samples taken at intervals. Immunoblotting was performed on sera obtained 16 years after the vaccination. In general, antibody studies have demonstrated some decline in antibody titres after the initial measles vaccination. However, a temporary moderate increase in measles antibodies occurred in some individuals 2-4 years after vaccination, probably due to a reinfection of vaccinees. Most of these individuals did not have demonstrable IgA antibodies prior to the supposed reinfection.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3532604     DOI: 10.1016/0264-410x(86)90006-x

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  5 in total

1.  Secondary immune response in a vaccinated population during a large measles epidemic.

Authors:  G Ozanne; M A d'Halewyn
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

2.  Duration of immunity following immunization with live measles vaccine: 15 years of observation in Zhejiang Province, China.

Authors:  B Dai; Z H Chen; Q C Liu; T Wu; C Y Guo; X Z Wang; H H Fang; Y Z Xiang
Journal:  Bull World Health Organ       Date:  1991       Impact factor: 9.408

3.  Evaluation of monoclonal antibody-based capture enzyme immunoassays for detection of specific antibodies to measles virus.

Authors:  D D Erdman; L J Anderson; D R Adams; J A Stewart; L E Markowitz; W J Bellini
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

4.  Passive hemagglutination test for measles immunity and serodiagnosis.

Authors:  H Sakata; A Sugiura
Journal:  J Clin Microbiol       Date:  1988-04       Impact factor: 5.948

5.  Evaluation of hemagglutinin protein-specific immunoglobulin M for diagnosis of measles by an enzyme-linked immunosorbent assay based on recombinant protein produced in a high-efficiency mammalian expression system.

Authors:  F B Bouche; N H Brons; S Houard; F Schneider; C P Muller
Journal:  J Clin Microbiol       Date:  1998-12       Impact factor: 5.948

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.